Xu Qiaohua, Zhou Maigeng, Jin Donghui, Zeng Xinying, Qi Jinlei, Yin Li, Liu Yuan, Yin Lei, Huang Yuelong
Department of NCDs Control and Prevention, Hunan Provincial Center for Disease Control and Prevention, Changsha, Hunan, China.
National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
PeerJ. 2020 Nov 3;8:e10298. doi: 10.7717/peerj.10298. eCollection 2020.
In 2011, the United Nations set a target to reduce premature mortality from non-communicable diseases (NCDs) by 25% by 2025. While studies have reported the target in some countries, no studies have been done in China. This study aims to project the ability to reach the target in Hunan Province, China, and establish the priority for future interventions.
We conducted the study during 2019-2020. From the Global Burden of Disease Study 2016, we extracted death data for Hunan during 1990-2016 for four main NCDs, namely cancer, cardiovascular disease (CVD), chronic respiratory diseases, and diabetes. We generated estimates for 2025 by fitting a linear regression to the premature mortality over the most recent trend identified by a joinpoint regression model. We also estimated excess premature mortality attributable to unfavorable changes over time.
The rate of premature mortality from all NCDs in Hunan will be 19.5% (95% CI [19.0%-20.1%]) by 2025, with the main contributions being from CVD (8.2%, 95% CI [7.9%-8.5%]) and cancer (7.9%, 95% CI [7.8%-8.1%]). Overall, it will be impossible to achieve the target, with a relative reduction of 16.4%. Women may be able to meet the target except with respect to cancer, and men will not except with respect to chronic respiratory diseases. Most of the unfavorable changes have occurred since 2008-2009.
More urgent efforts, especially for men, should be exerted in Hunan by integrating population-wide interventions into a stronger health-care system. In the post lock-down COVID-19 era in China, reducing the NCD risk factors can also lower the risk of death from COVID-19.
2011年,联合国设定了到2025年将非传染性疾病(NCD)导致的过早死亡率降低25%的目标。虽然已有研究报告了一些国家实现该目标的情况,但中国尚未开展相关研究。本研究旨在预测中国湖南省实现该目标的能力,并确定未来干预措施的重点。
我们在2019 - 2020年期间开展了此项研究。从《2016年全球疾病负担研究》中,我们提取了湖南省1990 - 2016年期间四种主要非传染性疾病(即癌症、心血管疾病(CVD)、慢性呼吸道疾病和糖尿病)的死亡数据。通过对连接点回归模型确定的最近趋势下的过早死亡率进行线性回归拟合,我们得出了对2025年的估计值。我们还估计了随时间不利变化导致的额外过早死亡率。
到2025年,湖南省所有非传染性疾病导致的过早死亡率将为19.5%(95%置信区间[19.0% - 20.1%]),主要贡献来自心血管疾病(8.2%,95%置信区间[7.9% - 8.5%])和癌症(7.9%,95%置信区间[7.8% - 8.1%])。总体而言,实现该目标是不可能的,相对降低幅度为16.4%。除癌症外,女性可能能够实现该目标,而男性除慢性呼吸道疾病外无法实现该目标。大多数不利变化自2008 - 2009年以来就已出现。
在湖南省应做出更紧迫的努力,特别是针对男性,通过将全人群干预措施纳入更强大的医疗保健系统来实现。在中国新冠疫情解封后的时代,降低非传染性疾病风险因素也可降低新冠死亡风险。